Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrace in advanced breast cancer
NCT00661531Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Apr 2008
- Primary completion
- Jun 2015
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of estradiol in breast cancer, sponsored by Georgetown University. Primary endpoint: Progression Free Survival at 6 months. Started Apr 2008; status: terminated.
02
Drugs
estradiol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00661531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661531.